282 related articles for article (PubMed ID: 26022889)
1. Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin.
Tajiri T; Morita S; Sakamoto R; Mimura H; Ozaki Y; Reppas C; Kitamura S
Int J Pharm; 2015 Jul; 490(1-2):368-74. PubMed ID: 26022889
[TBL] [Abstract][Full Text] [Related]
2. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.
Ohara T; Kitamura S; Kitagawa T; Terada K
Int J Pharm; 2005 Sep; 302(1-2):95-102. PubMed ID: 16102924
[TBL] [Abstract][Full Text] [Related]
3. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
5. Preparation of extended release solid dispersion formulations of tacrolimus using ethylcellulose and hydroxypropylmethylcellulose by solvent evaporation method.
Tsunashima D; Yamashita K; Ogawara K; Sako K; Higaki K
J Pharm Pharmacol; 2016 Mar; 68(3):316-23. PubMed ID: 26773717
[TBL] [Abstract][Full Text] [Related]
6. Hydrophilic-hydrophobic polymer blend for modulation of crystalline changes and molecular interactions in solid dispersion.
Van Ngo H; Nguyen PK; Van Vo T; Duan W; Tran VT; Tran PH; Tran TT
Int J Pharm; 2016 Nov; 513(1-2):148-152. PubMed ID: 27613254
[TBL] [Abstract][Full Text] [Related]
7. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
[TBL] [Abstract][Full Text] [Related]
8. Development of a Sustained Release Solid Dispersion Using Swellable Polymer by Melting Method.
Nguyen TN; Tran PH; Van Vo T; Duan W; Truong-Dinh Tran T
Pharm Res; 2016 Jan; 33(1):102-9. PubMed ID: 26264511
[TBL] [Abstract][Full Text] [Related]
9. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging.
Ewing AV; Clarke GS; Kazarian SG
Eur J Pharm Sci; 2014 Aug; 60():64-71. PubMed ID: 24832964
[TBL] [Abstract][Full Text] [Related]
10. Understanding and managing the impact of HPMC variability on drug release from controlled release formulations.
Zhou D; Law D; Reynolds J; Davis L; Smith C; Torres JL; Dave V; Gopinathan N; Hernandez DT; Springman MK; Zhou CC
J Pharm Sci; 2014 Jun; 103(6):1664-72. PubMed ID: 24652662
[TBL] [Abstract][Full Text] [Related]
11. Sustained Release of Poorly Water-Soluble Drug from Hydrophilic Polymeric Film Sandwiched Between Hydrophobic Layers.
Kevadiya BD; Zhang L; Davé RN
AAPS PharmSciTech; 2018 Aug; 19(6):2572-2584. PubMed ID: 29948990
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Microcentrifuge Dissolution Method as a Tool for Spray-Dried Dispersion.
Wu B; Li J; Wang Y
AAPS J; 2016 Mar; 18(2):346-53. PubMed ID: 26831250
[TBL] [Abstract][Full Text] [Related]
13. The Properties of HPMC:PEO Extended Release Hydrophilic Matrices and their Response to Ionic Environments.
Hu A; Chen C; Mantle MD; Wolf B; Gladden LF; Rajabi-Siahboomi A; Missaghi S; Mason L; Melia CD
Pharm Res; 2017 May; 34(5):941-956. PubMed ID: 27633887
[TBL] [Abstract][Full Text] [Related]
14. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
Xie T; Gao W; Taylor LS
Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices.
Ghori MU; Ginting G; Smith AM; Conway BR
Int J Pharm; 2014 Apr; 465(1-2):405-12. PubMed ID: 24560637
[TBL] [Abstract][Full Text] [Related]
16. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method.
Pillay V; Fassihi R
J Control Release; 1998 Oct; 55(1):45-55. PubMed ID: 9795013
[TBL] [Abstract][Full Text] [Related]
18. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release.
Andreas CJ; Chen YC; Markopoulos C; Reppas C; Dressman J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):39-50. PubMed ID: 26391972
[TBL] [Abstract][Full Text] [Related]
19. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
20. Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution.
Tay T; Allahham A; Morton DA; Stewart PJ
J Pharm Sci; 2011 Oct; 100(10):4269-80. PubMed ID: 21560127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
